DOI record:
{
"DOI": "10.1097/mjt.0000000000001441",
"ISSN": [
"1075-2765"
],
"URL": "http://dx.doi.org/10.1097/MJT.0000000000001441",
"author": [
{
"affiliation": [
{
"name": "School of Pharmacy, Monash University Malaysia Bandar Sunway, Selangor, Malaysia"
},
{
"name": "School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia"
}
],
"family": "Kow",
"given": "Chia Siang",
"sequence": "first"
},
{
"affiliation": [
{
"name": "School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom"
},
{
"name": "School of Biomedical Sciences and Pharmacy University of Newcastle, Callaghan, Australia"
}
],
"family": "Hasan",
"given": "Syed S.",
"sequence": "additional"
}
],
"container-title": "American Journal of Therapeutics",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2021,
8,
13
]
],
"date-time": "2021-08-13T13:55:18Z",
"timestamp": 1628862918000
},
"deposited": {
"date-parts": [
[
2023,
9,
17
]
],
"date-time": "2023-09-17T04:19:01Z",
"timestamp": 1694924341000
},
"indexed": {
"date-parts": [
[
2023,
9,
18
]
],
"date-time": "2023-09-18T04:35:25Z",
"timestamp": 1695011725354
},
"is-referenced-by-count": 4,
"issue": "5",
"issued": {
"date-parts": [
[
2021,
8,
6
]
]
},
"journal-issue": {
"issue": "5",
"published-online": {
"date-parts": [
[
2021
]
]
}
},
"language": "en",
"link": [
{
"URL": "https://journals.lww.com/10.1097/MJT.0000000000001441",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "276",
"original-title": [],
"page": "e616-e619",
"prefix": "10.1097",
"published": {
"date-parts": [
[
2021,
8,
6
]
]
},
"published-online": {
"date-parts": [
[
2021,
9
]
]
},
"publisher": "Ovid Technologies (Wolters Kluwer Health)",
"reference": [
{
"DOI": "10.1016/S1473-3099(20)30120-1",
"article-title": "An interactive web-based dashboard to track COVID-19 in real time",
"author": "Dong",
"doi-asserted-by": "crossref",
"first-page": "533",
"journal-title": "Lancet Infect Dis.",
"key": "R1-20230917",
"volume": "20",
"year": "2020"
},
{
"article-title": "The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review",
"author": "Thiruchelvam",
"journal-title": "Expert Rev Anti Infect Ther.",
"key": "R2-20230917",
"year": "2021"
},
{
"DOI": "10.1080/17476348.2021.1925546",
"article-title": "Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials",
"author": "Hasan",
"doi-asserted-by": "crossref",
"journal-title": "Expert Rev Respir Med.",
"key": "R3-20230917",
"year": "2021"
},
{
"DOI": "10.1007/s43440-021-00245-z",
"article-title": "The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis",
"author": "Kow",
"doi-asserted-by": "crossref",
"journal-title": "Pharmacol Rep.",
"key": "R4-20230917",
"year": "2021"
},
{
"DOI": "10.1016/j.antiviral.2020.104787",
"article-title": "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro",
"author": "Caly",
"doi-asserted-by": "crossref",
"first-page": "104787",
"journal-title": "Antivir Res",
"key": "R5-20230917",
"volume": "178",
"year": "2020"
},
{
"DOI": "10.1371/journal.pbio.3001162",
"article-title": "The methodological quality of 176,620 RCTs published between 1966 and 2018 reveals a positive trend but also an urgent need for improvement",
"author": "Vinkers",
"doi-asserted-by": "crossref",
"first-page": "e3001162",
"journal-title": "PLoS Biol.",
"key": "R6-20230917",
"volume": "19",
"year": "2021"
},
{
"DOI": "10.1016/j.ijid.2020.09.1470",
"article-title": "Use of hydroxychloroquine and chloroquine in COVID-19: how good is the quality of RCTs?",
"author": "Mazhar",
"doi-asserted-by": "crossref",
"first-page": "107",
"journal-title": "Int J Infect Dis.",
"key": "R7-20230917",
"volume": "101",
"year": "2020"
},
{
"DOI": "10.1016/j.chest.2020.03.010",
"article-title": "Sample size estimation in clinical research: from RCTs to observational studies",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "S12",
"journal-title": "Chest",
"key": "R8-20230917",
"volume": "158",
"year": "2020"
},
{
"DOI": "10.1097/MJT.0000000000001402",
"article-title": "Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines",
"author": "Bryant",
"doi-asserted-by": "crossref",
"first-page": "e434",
"journal-title": "Am J Ther.",
"key": "R9-20230917",
"volume": "28",
"year": "2021"
},
{
"DOI": "10.1056/NEJMoa2021436",
"article-title": "Dexamethasone in hospitalized patients with covid-19",
"author": "Horby",
"doi-asserted-by": "crossref",
"first-page": "693",
"journal-title": "N Engl J Med.",
"key": "R10-20230917",
"volume": "384",
"year": "2021"
},
{
"DOI": "10.1186/s12874-020-01101-z",
"article-title": "Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients",
"author": "Rai",
"doi-asserted-by": "crossref",
"first-page": "220",
"journal-title": "BMC Med Res Methodol",
"key": "R11-20230917",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1001/jama.2021.3071",
"article-title": "Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial",
"author": "López-Medina",
"doi-asserted-by": "crossref",
"first-page": "1426",
"journal-title": "JAMA",
"key": "R12-20230917",
"volume": "325",
"year": "2021"
},
{
"article-title": "Ivermectin as a potential treatment for mild to moderate COVID-19—a double blind randomized placebo-controlled trial",
"author": "Ravikirti",
"first-page": "10",
"journal-title": "medRxiv",
"key": "R14-20230917",
"volume": "2021",
"year": "2021"
},
{
"DOI": "10.1080/20477724.2021.1890887",
"article-title": "Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection",
"author": "Galan",
"doi-asserted-by": "crossref",
"first-page": "235",
"journal-title": "Pathog Glob Health",
"key": "R15-20230917",
"volume": "115",
"year": "2021"
},
{
"article-title": "Efficacy and safety of ivermectin and hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial",
"author": "Gonzalez",
"journal-title": "Preprint Medrxiv.",
"key": "R16-20230917",
"year": "2021"
},
{
"article-title": "Controlled randomized clinical trial on using ivermectin with doxycycline for treating COVID-19 patients in Baghdad, Iraq",
"author": "Hashim",
"journal-title": "Preprint Medrxiv.",
"key": "R17-20230917",
"year": "2020"
},
{
"DOI": "10.1186/s12879-021-06104-9",
"article-title": "Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients",
"author": "Okumus",
"doi-asserted-by": "crossref",
"first-page": "411",
"journal-title": "BMC Infect Dis",
"key": "R18-20230917",
"volume": "21",
"year": "2021"
},
{
"article-title": "Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial",
"author": "Niaee",
"journal-title": "Preprint Res Square",
"key": "R19-20230917",
"year": "2020"
},
{
"article-title": "Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
"author": "Horby",
"journal-title": "Preprint Medrxiv.",
"key": "R20-20230917",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(21)00149-5",
"article-title": "Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
"doi-asserted-by": "crossref",
"first-page": "605",
"journal-title": "Lancet",
"key": "R21-20230917",
"volume": "397",
"year": "2021"
},
{
"DOI": "10.1056/NEJMoa2022926",
"article-title": "Effect of hydroxychloroquine in hospitalized patients with covid-19",
"author": "Horby",
"doi-asserted-by": "crossref",
"first-page": "2030",
"journal-title": "N Engl J Med.",
"key": "R22-20230917",
"volume": "383",
"year": "2020"
},
{
"article-title": "Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
"author": "Horby",
"first-page": "55",
"journal-title": "Preprint Medrxiv.",
"key": "R23-20230917",
"volume": "2021",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(21)00897-7",
"article-title": "Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial",
"doi-asserted-by": "crossref",
"first-page": "2049",
"journal-title": "Lancet",
"key": "R24-20230917",
"volume": "397",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(20)32013-4",
"article-title": "Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
"doi-asserted-by": "crossref",
"first-page": "1345",
"journal-title": "Lancet",
"key": "R25-20230917",
"volume": "396",
"year": "2020"
}
],
"reference-count": 24,
"references-count": 24,
"relation": {},
"resource": {
"primary": {
"URL": "https://journals.lww.com/10.1097/MJT.0000000000001441"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19",
"type": "journal-article",
"volume": "28"
}
